Stockreport

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® [Yahoo! Finance]

Valneva SE - American Depositary Shares  (VALN) 
PDF maintaining neutralizing antibody titers above the seroresponse threshold. The results confirm a strong and long-lasting antibody persistence across all age groups, incl [Read more]